Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial

Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The update appears to reflect only minor UI/layout changes with no alterations to core study content (title, BRCA mutation, interventions, outcomes, or eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-27T21:04:33.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:26:44.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Page version updated to v3.1.0; removal of the term 'Ovarian cancer'.
    Difference
    0.1%
    Check dated 2025-09-29T04:56:43.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2 and removed the 'Back to Top' element. No other core content or key information appears to have changed.
    Difference
    0.1%
    Check dated 2025-09-14T22:53:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T19:41:14.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations related to ovarian cancer treatment, as well as the inclusion of a new study on rucaparib for relapsed ovarian cancer. Several previous entries have been removed, particularly those related to locations and cancer types.
    Difference
    8%
    Check dated 2025-08-31T12:29:33.000Z thumbnail image

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.